Although effective, PTH replacement is still not a viable option for hypoparathyroidism therapy (8); therefore, replacing calcium and the active form of vitamin D (1,25-dihydroxyvitaminD) are necessary. The gene discussed is PTH; the disease is hypoparathyroidism.